C CHEMED CORP NEW
| Market Cap | $5.71B |
| P/E Ratio | 22.07 |
| Forward P/E | 15.09 |
| Dividend Yield | 0.56% |
| Beta | 0.46 |
| 52W Range | $385.00 - $623.61 |
| # Hedge Funds | 0 |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
Hedge Fund Ownership
| Investor 0 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|
Insider Trading
| Insider Name of the company insider who made the trade 4 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Kevin J Mcnamarapresident and CEO | Sale | 1,500 | $369.37 | $554.05K | 27 Mar 2026 | 30 Mar 2026 |
| MCNAMARA KEVIN Jpresident and CEO | Sale | 2,000 | $403.18 | $806.36K | 12 Mar 2026 | 13 Mar 2026 |
| MCNAMARA KEVIN Jpresident and CEO | Sale | 2,000 | $437.55 | $875.10K | 24 Nov 2025 | 25 Nov 2025 |
| Kevin J Mcnamarapresident and CEO | Sale | 2,000 | $437.55 | $875.10K | 24 Nov 2025 | 25 Nov 2025 |
Frequently Asked Questions
What is CHE stock price today?
CHEMED CORP NEW (CHE) is currently trading at $404.90. The stock has a 52-week range of $385.00 to $623.61 and a market capitalization of $5.71B.
Is CHE a good stock to buy in 2026?
CHEMED CORP NEW has a P/E ratio of 22.1 (forward P/E: 15.1), a dividend yield of 0.56%, and 1-year performance of -31.6%. 0 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling CHE stock?
There have been 4 insider transactions for CHE in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has CHE stock performed over the past year?
CHEMED CORP NEW (CHE) has returned -31.6% over the past 12 months. The stock traded between $385.00 and $623.61 during this period, and is currently at $404.90.
Which hedge funds own CHE (CHEMED CORP NEW)?
0 tracked hedge funds currently hold CHE in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is CHE's market cap and valuation?
CHEMED CORP NEW (CHE) has a market capitalization of $5.71B. The trailing P/E ratio is 22.1 and forward P/E is 15.1. The stock is classified in the Healthcare sector.
What is CHE's revenue and profitability?
CHEMED CORP NEW reported revenue of $2.53B with net income of $265.24M and a profit margin of 0.10%. The stock has a beta of 0.46.
What sector is CHE in and who are its biggest institutional holders?
CHEMED CORP NEW (CHE) operates in the Healthcare sector. It is held by 0 tracked hedge funds. See the ownership table above for the complete list.